News ItemNMBio Board Has Some New Faces for 2014
March 13, 2014 –
This year’s Board of Directors provides NMBio with a wide range of expertise. Our Board Members are leaders in the biotech industry as well as professionals in accounting, business development and patent law, our universities and our national laboratories.
Officers for 2014 are; Andrew Salazar, Technology Ventures Corporation, President; Mary Ortner, Biophagy, Vice-President; Janeen Vilven-Doggett, PhD, Peacock Myers PC, Secretary and Kimberly Pena, The Rogoff Firm, Treasurer.
Mark Burge, MD, Deputy-Director, UNM Health Science Center Clinical & Translational Science Ctr.
John Cousins, CEO, Food Sentry
Terry Dunlay, President and CEO, Intellicyt Corporation
Victor Esch, CEO, nanoMR
Richard Larson, MD, PhD, Executive Vice Chancellor, UNM Health Sciences Center
Charlotte Mobarak, PhD, Scientific Consultants, CNM
John Mott, PhD, Tech Transfer Division, Los Alamos National Laboratory
Stuart Rose, Founder, The BioScience Center
Shannon Sheehan, PhD, MBA, Protara Biomarkers
Michael Vickers, Director of Operations, Maas BiolAB, LLC